QCRH:NASDAQQCR Holdings, Inc. Analysis
Data as of 2026-04-27 - not real-time
$88.39
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
QCR Holdings has posted record profitability in the latest quarter, driven by robust loan and deposit expansion. Management reaffirmed double‑digit loan growth and lifted its capital‑markets revenue goal. The stock is trading comfortably above its short‑term and mid‑term moving averages, indicating momentum. Volume has been on the rise, supporting the price advance. Technical indicators show a bullish trend despite a marginally bearish MACD signal, suggesting near‑term consolidation. Support sits near a solid level, while resistance lies well above the current price, leaving room for upside. The relative strength index sits near the neutral zone, implying balanced buying pressure.
Valuation metrics reveal the company trades at a price‑to‑earnings multiple well below the industry average, pointing to an undervalued position. A low payout ratio combined with ample cash balances makes the dividend appear sustainable. The market’s fear‑and‑greed gauge is in the extreme‑greed zone, reflecting strong investor sentiment. Volatility is moderate and beta is close to one, indicating market‑aligned risk. Regulatory and geographic exposures are limited, keeping sector and currency risks at manageable levels. Overall, the combination of earnings growth, attractive valuation, and steady dividend supports a positive outlook. Investors should consider the stock for both short‑term upside and longer‑term stability.
Valuation metrics reveal the company trades at a price‑to‑earnings multiple well below the industry average, pointing to an undervalued position. A low payout ratio combined with ample cash balances makes the dividend appear sustainable. The market’s fear‑and‑greed gauge is in the extreme‑greed zone, reflecting strong investor sentiment. Volatility is moderate and beta is close to one, indicating market‑aligned risk. Regulatory and geographic exposures are limited, keeping sector and currency risks at manageable levels. Overall, the combination of earnings growth, attractive valuation, and steady dividend supports a positive outlook. Investors should consider the stock for both short‑term upside and longer‑term stability.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- price above short‑term and mid‑term moving averages
- increasing trading volume
- clear upside potential between support and resistance
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- strong loan growth outlook and record profitability
- valuation well below industry peers
- sustainable dividend with low payout ratio
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- exposure to regulatory changes in the banking sector
- moderate beta and volatility indicating market‑aligned risk
- steady cash position supporting dividend continuity
Key Metrics & Analysis
Financial Health
Revenue Growth21.10%
Profit Margin36.75%
P/E Ratio11.1
ROE12.57%
ROA1.44%
P/B Ratio1.3
Industry P/E17.3
Technical Analysis
TrendBullish
RSI49.4
Support$81.51
Resistance$94.09
MA 20$89.02
MA 50$87.39
MA 200$81.31
MACDBearish
VolumeIncreasing
Fear & Greed Index88.02
Valuation
Target Price$101.00
Upside/Downside14.27%
GradeUndervalued
TypeBlend
Dividend Yield0.45%
Risk Assessment
Beta0.98
Volatility18.79%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.